Federal investment in basic science built America’s innovation engine, but declining support is threatening U.S. leadership, ...

The mRNA revolution didn’t end with COVID-19 – it’s only just beginning. With the MHRA’s latest guidance on personalized mRNA cancer vaccines and the world’s first RNA-based CRISPR therapy changing ...

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.

Flashpoint Therapeutics, a biotechnology company pioneering the development of transformative nanomedicines, proudly congratulates its founder, Professor Chad A. Mirkin, on being named the recipient ...

The cancer biologics market presents significant opportunities driven by a rising global cancer incidence, increased R&D in personalized medicine, and advancements in biologic therapies like mRNA and ...

This leads to iron overload, which can have serious consequences for organs and joints. In preclinical studies, MHH researchers have already successfully treated this genetic defect using a targeted ...

ARPA-H gene editing program THRIVE awards $160 million to seven research teams tasked with building scalable base-editing ...

Explore 25 inventions that seem too good to be legal. From free energy to universal cures, these disruptive technologies ...

A massive, global review of mRNA vaccines has shown that they are very effective and safe. Reporting in The Lancet, researchers used data from... | Cell And Molecular Biology ...

Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC.

More than a quarter of the world's population is affected by helminth infections, which can profoundly alter the immune ...